RG
GMED icon

Redmile Group’s Globus Medical GMED Stock Holding History

Redmile Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-208,600
Closed -$8.57M – 68
2017
Q4 		$8.57M Buy
+208,600
New +$7.3M 0.37% 53
2015
Q2 		– Sell
-611,731
Closed -$15.4M – 58
2015
Q1 		$15.4M Hold
611,731
– – 1.39% 31
2014
Q4 		$14.5M Sell
611,731
-354,569
-37% -$7.85M 1.58% 32
2014
Q3 		$19M Buy
966,300
+133,312
+16% +$2.74M 2.2% 17
2014
Q2 		$19.9M Sell
832,988
-229,964
-22% -$5.55M 2.42% 18
2014
Q1 		$28.3M Sell
1,062,952
-23,685
-2% -$563K 3.37% 7
2013
Q4 		$21.9M Buy
1,086,637
+350,537
+48% +$6.51M 2.71% 12
2013
Q3 		$12.9M Buy
736,100
+35,400
+5% +$613K 1.94% 23
2013
Q2 		$11.8M Buy
+700,700
New +$10.8M 2.08% 19

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Redmile Group's GMED Position: Q1 2018 in Review

Redmile Group sold out of Globus Medical (GMED) in Q1 2018, closing a stake of 208,600 shares — an estimated $8.57M sold.

Redmile Group first reported a position in GMED in Q2 2013 and held it in 9 quarters. The position peaked at $28.3M in Q1 2014. 279 funds tracked by Wall St. Rank hold GMED as of Q1 2018.

  • Redmile Group reported no remaining Globus Medical position as of Q1 2018 after selling out during the quarter.
  • Redmile Group sold 208,600 Globus Medical shares in Q1 2018, an estimated $8.57M.
  • Redmile Group first reported a position in Globus Medical in Q2 2013 and held it in 9 quarters.
  • Redmile Group's Globus Medical position peaked at $28.3M in Q1 2014.
  • 279 funds tracked by Wall St. Rank held Globus Medical as of Q1 2018.

Based on Redmile Group's 13F filing for Q1 2018, filed 15 May 2018.